Skip to main content
. 2023 Aug 30;30(9):7984–8004. doi: 10.3390/curroncol30090580

Figure 2.

Figure 2

Mean annual cost per patient (EUR) by tumor location (90% of pharmaceutical antineoplastic expenditure) and study year.